iCAD narrows losses in Q2

iCAD, a developer of advanced image analysis and workflow technologies for the identification of cancer, has reported less income losses in its financial results for the second quarter, ending June 30. The company posted a net loss of $736,000, compared with a net loss of $1.4 million in the second quarter of 2009.

Total revenue for the second quarter of 2010 was $6.1 million, an increase of 6 percent compared with $5.7 million for the second quarter of 2009. iCAD said the gains reflect a 29 percent increase in revenue from its digital and MRI computer-aided detection (CAD) products to $4 million from $3.1 million in the prior year. The gains were offset by a 28 percent decline in international revenue to $868,000 from $1.2 million in the second quarter of 2009.

Total film-based revenue for the second quarter of 2010 declined 58 percent to $725,000 from $1.7 million in the second quarter of 2009. The Nashua, N.H.-based company said the decline can be attributed to the” expected continued decline” in the demand for film-based products and accessories as the marketplace continues to transition to digital technologies and to softer demand for digital mammography systems which affects sales of the TotalLook MammoAdvantage, a digitizing and comparative reading technology.

However, service and supply revenue increased 52 percent to $1.4 million from $908,000 in the prior year period, largely the result of solid growth in service contract revenue as digital CAD and TotalLook MammoAdvantage systems transition from warranty to service contracts.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup